|
WDR8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.012400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.705800E-01 |
| Normal-vs-Stage2 |
9.410400E-01 |
| Normal-vs-Stage3 |
9.842400E-01 |
| Normal-vs-Stage4 |
2.808300E-02 |
| Stage1-vs-Stage2 |
5.593800E-01 |
| Stage1-vs-Stage3 |
3.444000E-01 |
| Stage1-vs-Stage4 |
6.680200E-02 |
| Stage2-vs-Stage3 |
9.256600E-01 |
| Stage2-vs-Stage4 |
9.573500E-02 |
| Stage3-vs-Stage4 |
2.402400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.633200E-01 |
| Normal-vs-AfricanAmerican |
3.778000E-03 |
| Normal-vs-Asian |
4.096000E-03 |
| Caucasian-vs-AfricanAmerican |
1.100940E-03 |
| Caucasian-vs-Asian |
2.287900E-02 |
| AfricanAmerican-vs-Asian |
3.982000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.962800E-01 |
| Normal-vs-Female |
2.328200E-02 |
| Male-vs-Female |
2.823500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.519200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.026600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.904600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.188000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.006400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.195600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.817200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.208600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.824400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.900200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.578980E-03 |
| Normal-vs-Grade 2 |
1.586230E-01 |
| Normal-vs-Grade 3 |
6.375600E-01 |
| Normal-vs-Grade 4 |
5.615700E-02 |
| Grade 1-vs-Grade 2 |
4.540100E-02 |
| Grade 1-vs-Grade 3 |
1.523670E-03 |
| Grade 1-vs-Grade 4 |
7.276200E-02 |
| Grade 2-vs-Grade 3 |
1.871750E-02 |
| Grade 2-vs-Grade 4 |
3.017000E-01 |
| Grade 3-vs-Grade 4 |
1.338230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.762600E-01 |
| Normal-vs-ccB subtype |
4.512000E-01 |
| ccA subtype-vs-ccB subtype |
1.260760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.805200E-01 |
| Normal-vs-N1 |
5.187900E-02 |
| N0-vs-N1 |
3.665600E-02 |
|
|
